1.
Crit Rev Immunol
; 40(6): 537-542, 2020.
Artículo
en Inglés
| MEDLINE
| ID: mdl-33900697
RESUMEN
The pandemic caused by the SARS-CoV-2 has made new treatments a goal for the scientific community. One of these treatments is Ivermectin. Here we discuss the hypothesis of dysbiosis caused by the use of Ivermectin and the possible impacts on neuroinflammatory diseases after the end of the pandemic.